The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for G1 Therapeutics Inc. (GTHX) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.07, or -2.29%, to $2.99. The G1 Therapeutics Inc. has recorded 9,623 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed G1 Therapeutics Provides Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
G1 Therapeutics Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $3.06 and fluctuated between $3.1950 as its day high and $2.9500 as its day low. The current market capitalization of G1 Therapeutics Inc. is $162.70M. A total of 1.32 million shares were traded on the day, compared to an average of 1.29M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, GTHX has seen 8 BUY and 11 SELL insider trades, representing the acquisition of 207,400 and the disposition of 47,918 shares. Over the last 12 months, there were 17 BUYs and 17 SELLs from insiders. Insiders purchased 390,400 shares during that period but sold 182,214.
In the most recent transaction, Malik Rajesh sold 729 shares of GTHX for 5.41 per share on Jan 05. After the transaction, the Chief Medical Officer now owns 102,739 company shares. In a previous transaction on Jan 05, Hanson James S. sold 729 shares at 5.41 per share. GTHX shares that General Counsel owns now total 41,087.
Among the insiders who sold shares, Moses Jennifer K. disposed of 729 shares on Jan 05 at a per-share price of $5.41. This resulted in the CFO holding 57,820 shares of GTHX after the transaction. In another insider transaction, MURDOCK TERRY L sold 729 shares at $5.41 per share on Jan 05. Company shares held by the Chief Operating Officer now total 36,439.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for GTHX in the last 3 months, the mean price target is $13.83 with high estimates of $24.00 and low estimates of $5.00. In terms of 52-week highs and lows, GTHX has a high of $17.49 and a low of $3.15.
As of this writing, GTHX has an earnings estimate of -$0.81 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.68 per share and a lower estimate of -$0.88. The company reported an EPS of -$0.92 in the last quarter, which was 9.80% higher than expectations of -$1.02.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 8 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GTHX is Overweight with a score of 4.43. A total of 6 analysts rated the stock as Buy while 1 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.